Skip to main content

COVID-19 Alert for Cancer Patients

The Vanderbilt-Ingram Cancer Center is following the COVID-19 pandemic closely and taking steps to protect our patients and our staff. Please be assured that we are here for you.

*Updated September 11, 2020*

We will be diligently updating information on a regular basis for specific diseases and conditions.

For cancer info, click here.
Para más información en Español sobre cáncer visite la siguiente página.

For the latest info about coronavirus for VUMC patients and visitors.

For the latest VUMC restricted visitor policy.

 

 Partners in Discovery

Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.

No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer. 

Proven Track Record

A leader in research, innovation and treatment. We are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.

NCI badge

Patients, Partners, Progress

Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.    

Read their stories from Momentum magazine. 

Cancer Center News

Latest news about our research, patient care programs, outreach and educational events.

Peal named Cancer Center associate operating officer

Karline Peal, MBA, BS, AS, RTT, was recently named associate operating officer of Vanderbilt-Ingram Cancer Center.

Vanderbilt Health Belle Meade opens Jan. 18

Vanderbilt Health Belle Meade, a 50,000-square-foot outpatient facility that offers additional space for urology, orthopaedic and oncology services, along with cancer infusion therapy, opens Jan. 18.

Pal named to cancer research national leadership posts

Tuya Pal, MD, Ingram Professor of Cancer Research and associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center, has been named to two cancer research leadership posts.

Study reveals new strategy for reducing tumor growth, metastasis

Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.

Rini to lead NCI study of COVID-19 in cancer patients

Brian Rini, MD, is leading a study launched by NCI that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.

Lovly to chair foundation’s scientific leadership board

Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).